143 related articles for article (PubMed ID: 7575600)
1. Structure of prejunctional receptor binding analog of human neuropeptide Y dimer ANA-NPY.
Barden JA
Biochem Biophys Res Commun; 1995 Oct; 215(1):264-71. PubMed ID: 7575600
[TBL] [Abstract][Full Text] [Related]
2. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
[TBL] [Abstract][Full Text] [Related]
3. Effects of covalent dimerization on the structure and function of the carboxy-terminal fragment of neuropeptide Y.
Uegaki K; Murase S; Nemoto N; Kobayashi Y; Yoshikawa S; Yumoto N
Biochem Biophys Res Commun; 1997 Dec; 241(3):737-43. PubMed ID: 9434778
[TBL] [Abstract][Full Text] [Related]
4. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
Lerch M; Mayrhofer M; Zerbe O
J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255
[TBL] [Abstract][Full Text] [Related]
5. The contribution of helical potential to the in vitro receptor binding activity of a neuropeptide Y N-terminal deletion fragment.
Doughty MB; Hu L
Biopolymers; 1993 Aug; 33(8):1195-206. PubMed ID: 8364154
[TBL] [Abstract][Full Text] [Related]
6. Structure of the presynaptic (Y2) receptor-specific neuropeptide Y analog ANA-NPY.
Barden JA; Cuthbertson RM; Potter EK
Biochim Biophys Acta; 1995 Jul; 1250(1):83-9. PubMed ID: 7612657
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of alpha-helix in C-terminal fragments of neuropeptide Y.
Yumoto N; Murase S; Hattori T; Yamamoto H; Tatsu Y; Yoshikawa S
Biochem Biophys Res Commun; 1993 Nov; 196(3):1490-5. PubMed ID: 8250906
[TBL] [Abstract][Full Text] [Related]
8. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding.
Lerch M; Kamimori H; Folkers G; Aguilar MI; Beck-Sickinger AG; Zerbe O
Biochemistry; 2005 Jun; 44(25):9255-64. PubMed ID: 15966750
[TBL] [Abstract][Full Text] [Related]
9. Studies of the structure of the N-terminal domain from the Y4 receptor - a G protein-coupled receptor - and its interaction with hormones from the NPY family.
Zou C; Kumaran S; Markovic S; Walser R; Zerbe O
Chembiochem; 2008 Sep; 9(14):2276-84. PubMed ID: 18767100
[TBL] [Abstract][Full Text] [Related]
10. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
[TBL] [Abstract][Full Text] [Related]
11. Interaction of neuropeptide Y and Hsp90 through a novel peptide binding region.
Ishiwatari-Hayasaka H; Maruya M; Sreedhar AS; Nemoto TK; Csermely P; Yahara I
Biochemistry; 2003 Nov; 42(44):12972-80. PubMed ID: 14596612
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity analysis of N-acetyl [Leu(28,31)] NPY 24-36: a potent neuropeptide Y Y(2) receptor agonist.
Smith-White MA; Potter EK
Neuropeptides; 1999 Dec; 33(6):526-33. PubMed ID: 10657536
[TBL] [Abstract][Full Text] [Related]
13. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
[TBL] [Abstract][Full Text] [Related]
14. Alpha-helical small molecular size analogues of neuropeptide Y: structure-activity relationships.
Jung G; Beck-Sickinger AG; Dürr H; Gaida W; Schnorrenberg G
Biopolymers; 1991 May; 31(6):613-9. PubMed ID: 1657233
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic properties of centrally truncated analogs of [D-Trp(32)]NPY.
Balasubramaniam A; Ujhelyi M; Borchers M; Huang Y; Zhai W; Zhou Y; Johnson M; Sheriff S; Fischer JE
J Med Chem; 1996 Mar; 39(5):1142-7. PubMed ID: 8676351
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
Sautel M; Rudolf K; Wittneben H; Herzog H; Martinez R; Munoz M; Eberlein W; Engel W; Walker P; Beck-Sickinger AG
Mol Pharmacol; 1996 Aug; 50(2):285-92. PubMed ID: 8700135
[TBL] [Abstract][Full Text] [Related]
17. A rational approach for the development of reduced-size analogues of neuropeptide Y with high affinity to the Y1 receptor.
Rist B; Wieland HA; Willim KD; Beck-Sickinger AG
J Pept Sci; 1995; 1(5):341-8. PubMed ID: 9223013
[TBL] [Abstract][Full Text] [Related]
18. High affinity displacement of [(3)H]NPY binding to the crude venom of conus anemone by insect neuropeptides.
Le MT; Vanderheyden PM; De Backer JP; Vanquelin G; Broeck JV
Biochem Biophys Res Commun; 1999 Aug; 262(1):180-6. PubMed ID: 10448089
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors.
Beck-Sickinger AG; Jung G
Biopolymers; 1995; 37(2):123-42. PubMed ID: 7893945
[TBL] [Abstract][Full Text] [Related]
20. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
Fournier A; Gagnon D; Quirion R; Cadieux A; Dumont Y; Pheng LH; St-Pierre S
Mol Pharmacol; 1994 Jan; 45(1):93-101. PubMed ID: 8302286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
